Gavreto Capsule
Product Images NDC 71332-006

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gavreto (NDC 71332-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gavreto 01)

Chemical structure of pralsetinib, the active ingredient in Gavreto 100 mg capsules. The diagram shows the molecular arrangement, including rings, bonds, and stereochemistry labeled (cis) and (S), representing its specific 3D configuration.*

FDA Label Image

Principal Display Panel (100 mg Capsule Carton)

Box label for Gavreto (pralsetinib) capsules, 100 mg strength. The label indicates oral use, contains 60 capsules, and is distributed by Rigel Pharmaceuticals, Inc. The NDC number 71332-006-60 is shown. The label features the Rigel logo in the bottom right corner.*

FDA Label Image

Principal Display Panel (100 mg Capsule Carton)

Gavreto 100 mg capsules label displaying the prescription drug name, active ingredient pralsetinib, and oral dosage form. The label indicates a package of 90 capsules with the NDC 71332-006-90. It includes the Rigel Pharmaceuticals, Inc. logo and highlights that the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.